DailyTimeCapsule brief
January 27, 2019
On January 27, 2019, the U.S. government intensified its efforts to rally allies against China’s Huawei in the ongoing 5G technology race. This push was rooted in national security concerns, as officials maintained that Huawei could pose a threat due to its close ties to the Chinese government. At the same time, breakthroughs in medicine were emerging as experimental therapies showed promise in potentially curing patients with sickle-cell disease, a significant advancement in genetic healthcare. Economically, the world was grappling with persistently low growth and inflation, raising alarm among policymakers and economists who feared the implications for global markets and consumer confidence.
Key developments
-
As the global race to implement 5G technology intensifies, the Trump administration has been actively urging its allies to exclude Chinese telecom giant Huawei from their infrastructure plans. Officials argue that allowing Huawei's involvement could lead to significant national security risks, given the potential for the Chinese government to access sensitive data. The decisions made by allied nations in this crucial period are expected to shape global internet architecture and geopolitical dynamics for decades to come.
-
Recent experimental therapies have shown promising results in treating patients with sickle-cell disease, potentially marking a breakthrough in genetic medicine. These treatments focus on correcting the genetic mutations that cause sickle-cell disease, offering hope for long-term relief from the chronic pain and health complications associated with the condition. If successful on a larger scale, this could be the first-time common genetic disease receives an effective cure, affecting tens of thousands of lives in the U.S.
-
The World Economy Just Can’t Escape Its Low-Growth, Low-Inflation Rut
